UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Inflammation and Metabolic Complications in HIV

Current HIV/AIDS reports, 2018-10, Vol.15 (5), p.371-381

2018

Link zum Volltext

Verfügbarkeit prüfen

Weight Gain Among Treatment-Naïve Persons With HIV Receiving Dolutegravir in Kenya

Journal of acquired immune deficiency syndromes (1999), 2022-12, Vol.91 (5), p.490

2022

Link zum Volltext

Verfügbarkeit prüfen

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Journal of the International AIDS Society, 2020-04, Vol.23 (4), p.e25484-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis

Journal of primary care & community health, 2020, Vol.11, p.2150132720984416-2150132720984416

2020

Link zum Volltext

Verfügbarkeit prüfen

Healthcare-associated necrotizing cutaneous mucormycosis: A case report

International Journal of Case Reports and Images (IJCRI), 2016-04, Vol.7 (4), p.232

2016

Link zum Volltext

Verfügbarkeit prüfen

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

Clinical infectious diseases, 2020-03, Vol.70 (7), p.1267-1274

2020

Link zum Volltext

Verfügbarkeit prüfen

1285-P: Disparities in Screening, Diagnosis, and Treatment of Type 2 Diabetes Mellitus among Persons with HIV

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations of HIV and Depression with Incident Diabetes Mellitus: Veterans Aging Cohort Study

Clinical infectious diseases, 2022-02, Vol.78 (2), p.378-385

2022

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis Meningitis

Current infectious disease reports, 2017-11, Vol.19 (11), p.39-39, Article 39

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Digestive diseases and sciences, 2017-10, Vol.62 (10), p.2870-2875

2017

Link zum Volltext

Verfügbarkeit prüfen

Associations of Human Immunodeficiency Virus (HIV) and Depression With Incident Diabetes Mellitus: Veterans Aging Cohort Study

Clinical infectious diseases, 2024-02

2024

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic Ovarian Vein Thrombosis in the Postmenopausal Age

International Journal of Case Reports and Images (IJCRI), 2013-11, Vol.4 (11), p.611

2013

Link zum Volltext

Verfügbarkeit prüfen

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e2153-e2163

2021

Link zum Volltext

Verfügbarkeit prüfen

Su1447 The Hepatitis C and HIV Co-Infected Patient: Time to Scale Up HCV Therapy at a Local Level

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1102-S1102

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Rebound Viremia in Treatment Experienced Patients with Undetectable Viral Load

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Sa1624 Risk Factors for Delayed-Onset Cytomegalovirus Disease in High Risk Liver Transplant Recipients Who Receive Antiviral Prophylaxis

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S1079-S1080

2016

Link zum Volltext

Verfügbarkeit prüfen

Preswitch Regimens Influence the Rate of Weight Gain After Switch to Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir (TLD): Study From an East African Cohort

Open forum infectious diseases, 2023-12, Vol.10 (12), p.ofad581-ofad581

2023

Link zum Volltext

Verfügbarkeit prüfen

False-positive cerebrospinal fluid cryptococcus antigen in Libman–Sacks endocarditis

Infection, 2016-12, Vol.44 (6), p.803-805

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis : A 10-Year Longitudinal Study

Open forum infectious diseases, 2017-03, Vol.4 (2), p.ofx045-ofx045

2017

Link zum Volltext

Verfügbarkeit prüfen

1286. Healthcare Provider Attitudes and Knowledge Around Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV-Infection in Tennessee

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S463-S463

2019

Link zum Volltext

Verfügbarkeit prüfen

1528Ralteragir Containing regimen, for Post Exposure Prophylaxis (PEP), well tolerated in Health Care Workers (HCW)

Open forum infectious diseases, 2014-12, Vol.1 (suppl_1), p.S405-S405

2014

Link zum Volltext

Verfügbarkeit prüfen

1333. Developing an Educational Tool to Improve Housestaff Knowledge, Attitudes, and Behavior in Managing Common Infectious Diseases

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S407-S407

2018

Link zum Volltext

Verfügbarkeit prüfen

LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S996-S997

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Infectious Diseases
(11)
Humans
(8)
Immunology
(8)
Hiv
(7)
Microbiology
(6)
Weight Gain
(6)
Female
(5)
Hiv Infections - Drug Therapy
(5)
Human Immunodeficiency Virus
(5)
Adult
(4)
Hiv Integrase Inhibitors - Therapeutic Use
(4)
Male
(4)
Medicine
(4)
Medicine & Public Health
(4)
Abstracts
(3)
Dolutegravir
(3)
Major
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inflammation and Metabolic Complications in HIV

Weight Gain Among Treatment-Naïve Persons With HIV Receiving Dolutegravir in Kenya

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis

Healthcare-associated necrotizing cutaneous mucormycosis: A case report

Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy

1285-P: Disparities in Screening, Diagnosis, and Treatment of Type 2 Diabetes Mellitus among Persons with HIV

Associations of HIV and Depression with Incident Diabetes Mellitus: Veterans Aging Cohort Study

Tuberculosis Meningitis

Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

Associations of Human Immunodeficiency Virus (HIV) and Depression With Incident Diabetes Mellitus: Veterans Aging Cohort Study

Idiopathic Ovarian Vein Thrombosis in the Postmenopausal Age

Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada

Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens

Su1447 The Hepatitis C and HIV Co-Infected Patient: Time to Scale Up HCV Therapy at a Local Level

Predictors of Rebound Viremia in Treatment Experienced Patients with Undetectable Viral Load

Sa1624 Risk Factors for Delayed-Onset Cytomegalovirus Disease in High Risk Liver Transplant Recipients Who Receive Antiviral Prophylaxis

Preswitch Regimens Influence the Rate of Weight Gain After Switch to Tenofovir Disoproxil Fumarate, Lamivudine, and Dolutegravir (TLD): Study From an East African Cohort

False-positive cerebrospinal fluid cryptococcus antigen in Libman–Sacks endocarditis

Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis : A 10-Year Longitudinal Study

1286. Healthcare Provider Attitudes and Knowledge Around Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV-Infection in Tennessee

Weight gain among treatment-na[euro]ive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

1528Ralteragir Containing regimen, for Post Exposure Prophylaxis (PEP), well tolerated in Health Care Workers (HCW)

1333. Developing an Educational Tool to Improve Housestaff Knowledge, Attitudes, and Behavior in Managing Common Infectious Diseases

LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

Suchergebnisse filtern